COVID-19 and pregnancy: Complications and mortality.

The pandemic caused by SARS-CoV-2, which causes the COVID-19 disease, has put the world in vulnerable conditions, leading to an unprecedented global crisis. Pregnant women are a special population that is used to being vulnerable to diseases diagnosed in pregnancy, especially the infectious kind. Th...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2022
Institución:
Pontificia Universidad Javeriana Cali
Repositorio:
Vitela
Idioma:
spa
OAI Identifier:
oai:vitela.javerianacali.edu.co:11522/450
Acceso en línea:
https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/644
https://vitela.javerianacali.edu.co/handle/11522/450
Palabra clave:
COVID-19
SARS-CoV-2
Embarazo
COVID-19
SARS-CoV-2
Pregnancy
Rights
License
Derechos de autor 2022 Salutem Scientia Spiritus
id Vitela2_0f427046c6e8cfbadb166fd8424afc0e
oai_identifier_str oai:vitela.javerianacali.edu.co:11522/450
network_acronym_str Vitela2
network_name_str Vitela
repository_id_str
spelling Ibarra, Jose FelixLeón-Cardona, Laura2022-09-302023-10-11T04:34:56Z2023-10-11T04:34:56Zhttps://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/644https://vitela.javerianacali.edu.co/handle/11522/450The pandemic caused by SARS-CoV-2, which causes the COVID-19 disease, has put the world in vulnerable conditions, leading to an unprecedented global crisis. Pregnant women are a special population that is used to being vulnerable to diseases diagnosed in pregnancy, especially the infectious kind. The objective of this review is to determine the level of risk of maternal mortality and complications in pregnant women exposed to SARS-CoV-2 infection by a literature review in PubMed, Science Direct and ClinicalKey with a systematic search in Pubmed. The result of this review showed that the risk level of SARS-CoV-2 in pregnant women is evidenced in the higher rate of mild, moderate and severe complications compared to the general population. The mortality rate in pregnant women with COVID-19 remains below 2% and in dead pregnant women, previous comorbidities have been reported in 20% in some studies.La pandemia ocasionada por el SARS-CoV-2, que ocasiona la enfermedad por COVID-19 ha puesto al mundo en condiciones vulnerables llegando a una crisis mundial sin precedentes. Las mujeres gestantes son una población especial que tienden a ser vulnerables ante las enfermedades diagnosticadas en el embarazo, especialmente las de origen infeccioso. El objetivo de está revisión es determinar el nivel de riesgo de mortalidad y complicaciones maternas en gestantes expuestas a la infección por SARS-CoV-2 por medio de una revisión de la literatura en PubMed, Science Direct y ClinicalKey con búsqueda sistemática en Pubmed. El resultado de está revisión mostró que el nivel de riesgo del SARS-CoV-2 en gestantes se evidencia en la mayor tasa de complicaciones leves, moderadas y severas comparado con la población general. La tasa de mortalidad en gestantes con COVID-19 se mantiene por debajo del 2% y en las gestantes muertas han reportado comorbilidades previas en un 20% en algunos estudios.application/pdfspaPontificia Universidad Javeriana Calihttps://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/644/547Derechos de autor 2022 Salutem Scientia Spiritushttps://creativecommons.org/licenses/by-nc-nd/4.0Salutem Scientia Spiritus; Vol. 8 No. 3 (2022): Revista Salutem Scientia Spiritus; 41-50Salutem Scientia Spiritus; Vol. 8 Núm. 3 (2022): Revista Salutem Scientia Spiritus; 41-502463-1426COVID-19SARS-CoV-2EmbarazoCOVID-19SARS-CoV-2PregnancyCOVID-19 and pregnancy: Complications and mortality.COVID-19 y embarazo: Complicaciones y mortalidad.info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionRevisión de la literatura11522/450oai:vitela.javerianacali.edu.co:11522/4502024-06-25 05:12:42.402metadata.onlyhttps://vitela.javerianacali.edu.coRepositorio Vitelavitela.mail@javerianacali.edu.co
dc.title.en-US.fl_str_mv COVID-19 and pregnancy: Complications and mortality.
dc.title.es-ES.fl_str_mv COVID-19 y embarazo: Complicaciones y mortalidad.
title COVID-19 and pregnancy: Complications and mortality.
spellingShingle COVID-19 and pregnancy: Complications and mortality.
Ibarra, Jose Felix
COVID-19
SARS-CoV-2
Embarazo
COVID-19
SARS-CoV-2
Pregnancy
title_short COVID-19 and pregnancy: Complications and mortality.
title_full COVID-19 and pregnancy: Complications and mortality.
title_fullStr COVID-19 and pregnancy: Complications and mortality.
title_full_unstemmed COVID-19 and pregnancy: Complications and mortality.
title_sort COVID-19 and pregnancy: Complications and mortality.
dc.creator.none.fl_str_mv Ibarra, Jose Felix
León-Cardona, Laura
author Ibarra, Jose Felix
author_facet Ibarra, Jose Felix
León-Cardona, Laura
author_role author
author2 León-Cardona, Laura
author2_role author
dc.subject.es-ES.fl_str_mv COVID-19
SARS-CoV-2
Embarazo
topic COVID-19
SARS-CoV-2
Embarazo
COVID-19
SARS-CoV-2
Pregnancy
dc.subject.en-US.fl_str_mv COVID-19
SARS-CoV-2
Pregnancy
description The pandemic caused by SARS-CoV-2, which causes the COVID-19 disease, has put the world in vulnerable conditions, leading to an unprecedented global crisis. Pregnant women are a special population that is used to being vulnerable to diseases diagnosed in pregnancy, especially the infectious kind. The objective of this review is to determine the level of risk of maternal mortality and complications in pregnant women exposed to SARS-CoV-2 infection by a literature review in PubMed, Science Direct and ClinicalKey with a systematic search in Pubmed. The result of this review showed that the risk level of SARS-CoV-2 in pregnant women is evidenced in the higher rate of mild, moderate and severe complications compared to the general population. The mortality rate in pregnant women with COVID-19 remains below 2% and in dead pregnant women, previous comorbidities have been reported in 20% in some studies.
publishDate 2022
dc.date.accessioned.none.fl_str_mv 2023-10-11T04:34:56Z
dc.date.available.none.fl_str_mv 2023-10-11T04:34:56Z
dc.date.none.fl_str_mv 2022-09-30
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
dc.type.es-ES.fl_str_mv Revisión de la literatura
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/644
dc.identifier.uri.none.fl_str_mv https://vitela.javerianacali.edu.co/handle/11522/450
url https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/644
https://vitela.javerianacali.edu.co/handle/11522/450
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/644/547
dc.rights.es-ES.fl_str_mv Derechos de autor 2022 Salutem Scientia Spiritus
https://creativecommons.org/licenses/by-nc-nd/4.0
rights_invalid_str_mv Derechos de autor 2022 Salutem Scientia Spiritus
https://creativecommons.org/licenses/by-nc-nd/4.0
dc.format.none.fl_str_mv application/pdf
dc.publisher.es-ES.fl_str_mv Pontificia Universidad Javeriana Cali
dc.source.en-US.fl_str_mv Salutem Scientia Spiritus; Vol. 8 No. 3 (2022): Revista Salutem Scientia Spiritus; 41-50
dc.source.es-ES.fl_str_mv Salutem Scientia Spiritus; Vol. 8 Núm. 3 (2022): Revista Salutem Scientia Spiritus; 41-50
dc.source.none.fl_str_mv 2463-1426
institution Pontificia Universidad Javeriana Cali
repository.name.fl_str_mv Repositorio Vitela
repository.mail.fl_str_mv vitela.mail@javerianacali.edu.co
_version_ 1812095052418121728

Publicaciones similares